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Abstract
Introduction: The cesarean section rate around the world, currently estimated at 
21.1%, continues to increase. Women who undergo a cesarean section sustain a 
seven- to ten- fold greater risk of infective morbidity compared with those who de-
liver vaginally.
Material and methods: We aimed to assess the impact of changing gloves intraopera-
tively on post- cesarean section infective morbidity (PROSPERO CRD42018110529). 
MEDLINE, Scopus, Web of Science, CINAHL, WHO Global Index Medicus, and 
Cochrane Central were searched for randomized controlled trials until June 2020. 
Published randomized controlled trials that evaluated the effects of glove chang-
ing during cesarean section on infective complications were considered eligible 
for the review. Two reviewers independently selected studies, assessed the risk 
of bias, and extracted data about interventions and adverse maternal outcomes. 
Dichotomous variables were presented and included in the meta- analyses as risk 
ratios (RR) with 95% confidence intervals (CI). The quality of evidence was as-
sessed using the GRADE approach in alignment with the recommendations from 
the Cochrane Review Group.
Results: We identified seven randomized controlled trials reporting data over 1948 
women. Changing gloves during a cesarean section was associated with a statisti-
cally significantly lower incidence of wound infective complications (RR 0.41, 95% CI 
0.26– 0.65, p < 0.0001; GRADE moderate quality evidence). This intervention seemed 
to be effective only if performed after delivery of the placenta. No significant differ-
ence was seen in the incidence of endometritis (RR 0.96, 95% CI 0.78– 1.20, p = 0.74; 
GRADE moderate quality evidence) and/or febrile morbidity (RR 0.73, 95% CI 0.30– 
1.81, p = 0.50; GRADE moderate quality evidence), regardless of the timing of the 
intervention.
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1  |  INTRODUC TION
Cesarean sections (CS) and its concomitant postoperative compli-
cations continue to grow. In 2015, CS represented 21.1% of all the 
deliveries worldwide with cases being disproportionally higher in 
Latin America and Oceania.1,2 CS is generally a safe procedure but is 
still a major laparotomy, which carries intra- and postoperative risks 
among which infection remains a leading cause of maternal morbid-
ity and mortality.3
Infection is seven to ten times more likely after CS than after 
vaginal delivery, especially as an emergency procedure.1 Surgical site 
infections (SSI) are one of the commonest infective complications 
with an estimated incidence of 3%– 15%4,5 and are associated with 
adverse maternal outcomes, poorer maternal– newborn bonding, 
longer hospitalization times and higher costs.6
Broad- spectrum prophylactic antibiotics during CS re-
duce wound infection and serious complications by at least 
60%– 70%.7– 10 However, its indiscriminate use has resulted in 
multi- resistant organisms and intractable wound infections. No 
other measure on its own has led to substantial SSI reduction, per-
haps because of limited insight into the exact pathophysiology of 
wound infections.11– 15
Significant amounts of non- staphylococcal bacteria were cul-
tured from the dorsal aspect of surgeons’ gloves after delivery by 
CS, which may derive from contact with the vaginal wall or the endo-
cervical canal.16 Based on these findings, the contaminated gloves 
were proposed to seed the pelvic cavity and layers of the abdominal 
wall with vaginal bacteria when reintroduced into the endometrial 
cavity during CS and coming in contact with the highly vascular-
ized endometrial placental bed.16,17 Therefore, small randomized 
controlled trials (RCTs) in the mid- 1990s tested whether changing 
gloves intraoperatively might reduce infection after CS. However, 
no clinical consensus was reached because the studies lacked pow-
er.18– 20 A series of new studies re- explored this practice, reviving 
interest in this simple yet potentially effective intervention.17,21
This systematic review and meta- analysis aims to comprehen-
sively evaluate the strength of the available evidence to determine 
whether changing gloves during CS reduces the risk of postopera-
tive infections in the hope of informing future research and guiding 
clinical practice.
2  |  MATERIAL AND METHODS
2.1  |  Protocol, search strategies, and sources
The protocol for this systematic review was based on PRISMA 
guidelines, and registered a priori in PROSPERO in 2018 
(CRD42018110529).
We systematically searched MEDLINE, Scopus, Web of Science, 
CINAHL, WHO Global Index Medicus, and Cochrane Central for 
RCTs on the effects of changing gloves intraoperatively in postop-
erative infectious morbidity from inception until June 2020 with no 
language restriction.
In addition to the aforementioned searches of electronic data-
bases, we also hand- checked all reference lists of identified trials 
and other relevant articles. We contacted trial authors where there 
was insufficient information regarding the outcomes or other rele-
vant methodological aspects of the trial.22
Our strategy search consisted of a relevant combination of 
Medical Subject Headings (MeSH), core search terms and synonyms 
for cesarean section, gloves, and infection (Appendix S1).
2.2  |  Eligibility criteria and study selection
All RCTs or quasi- RCTs in which at least one arm assessed the 
impact of intraoperatively changing gloves on infection were 
considered for inclusion. RCTs that evaluated glove change in 
surgeries other than CS or that did not specifically analyze and 
report on postoperative complications were excluded. No ob-
servational studies, anecdotal evidence, or animal studies were 
included.
Conclusions: Changing gloves after delivery of the placenta during a cesarean sec-
tion is associated with a significant reduction in the incidence of post- surgical wound 
complications compared with keeping the same gloves throughout the whole sur-
gery. However, an adequately powered study to assess the limitations and cost- 
effectiveness of the intervention is needed before this recommendation can be 
translated into current clinical practice.
K E Y W O R D S
cesarean section, changing gloves, endometritis, infection, postoperative morbidity
Key message
Implementing glove changing practices during cesarean 
sections can significantly reduce postoperative surgical 
site infections.
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All studies assessing pregnant women undergoing CS were con-
sidered for inclusion regardless of age, country of origin, body mass 
index, CS category of urgency, indication for surgery, and/or pre- 
existent comorbidities.
Although an effort was made to obtain the full text of all short-
listed studies, abstracts and conferences, procedures with enough 
information for analysis were also considered for inclusion to mini-
mize the risk of publication bias.
2.3  |  Data collection and outcomes
Two authors (BFN and JRA) independently extracted data from the 
included trials using a standardized data extraction form. The eligi-
bility and quality of each study was assessed independently by these 
two investigators. In case of disagreement, a consensus was reached 
by a third investigator (PM).
The primary outcome was defined as the incidence of 
wound infective complications understood as per the Centers 
for Disease Control and Prevention definition of superficial and 
deep SSIs, i.e. postoperative infections involving the skin, sub-
cutaneous tissue, and deep soft tissues of the incision (fascial 
and muscle layers).23– 25 The report of this outcome varied across 
studies and included a wide spectrum of presentations such as 
wound infection, serous drainage, induration, pus, and gaping 
(Table 1). For secondary outcomes, we included clinical endo-
metritis (we accepted any definition of endometritis understood 
as raised temperature and uterine tenderness) and febrile mor-
bidity (defined as persistent raised temperature without a clear 
focus of infection; Table 1).
Further subgroup analysis was performed based on the tim-
ing of the intervention, that is, whether gloves had been changed 
after delivery of the baby but before delivery of the placenta, or 
after delivery of the placenta but before closing the abdominal 
wall.
2.4  |  Risk of bias
Two review authors (BFN, JRA) independently assessed the risk 
of bias of the included trials using the Cochrane Risk of bias 
tool.26 We evaluated random sequence generation (selection 
bias); allocation concealment (selection bias); blinding of par-
ticipants or personnel (performance bias); blinding of outcome 
assessment (detection bias); completeness of outcome data (at-
trition bias); selective reporting (reporting bias); and other po-
tential sources of bias. We resolved any differences in opinion 
by discussion. Where disagreement persisted, we consulted a 
third party (PM). Poorly reported trials were judged as unclear 
risk of bias. This analysis proved essential to aid interpretation 
of overall findings, identify potential sources of heterogeneity 
across studies, and guide the grading and strength of the body 
of evidence available.
2.5  |  Measures of effect
Processing of data from the included trials was carried out according 
to the Cochrane Handbook for Systematic Reviews of Interventions.26 
The outcomes were quantitatively analyzed using REvIEw MANAgER 5 
(Cochrane Collaboration) and MEdCAlC®. For all outcomes, we calcu-
lated risk ratio (RR) with 95% confidence intervals (CI).
2.6  |  Dealing with missing data
As far as possible, we analyzed data on an intention- to- treat basis, 
meaning that the analysis of patients was according to the groups to 
which they were originally randomized. However, if data were miss-
ing, we used the numbers as reported by the authors.
2.7  |  Sensitivity analysis
We planned to perform sensitivity analyses to determine the effects 
of including or excluding trials at a high risk of bias. However, given 
the limited number of studies, such an approach was not always 
feasible.
2.8  |  Assessment of heterogeneity and 
subgroup analysis
Trial heterogeneity indices (I2) were interpreted as low (<30%), mod-
erate (30%– 60%), or high (>60%). When noticed to be high, we at-
tempted to perform subgroup analyses to assess whether timing of 
the intervention, for example, could account for some of the het-
erogeneity seen across studies. We used a random effect model to 
combine trials with similar interventions and report means of the 
observed effect. We favored a random effect over a fixed effect 
model based on the assumption that estimates of effect are likely 
to vary across studies not only because of sampling variability but 
also through a true difference in the intervention effect.27 We did 
not choose the meta- analysis model based on the trial heterogene-
ity test.28
2.9  |  Assessment of publication bias
For the evaluation of potential publication bias and small- study 
effect in our meta- analysis, we employed funnel plots, which 
were first assessed visually and subsequently with the Egger's 
test using MEdCAlC® (version 19.6.4). For funnel plots with fewer 
than ten studies, we interpreted the results with caution, being 
aware that they may not detect publication bias (type II error 
due to small number of studies).29 Symmetric funnel plots were 
considered indicative of low risk of significant publication bias, 
whereas asymmetric plots suggested significant publication bias. 
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design Country Study period Sample size Inclusion criteria Outcomes
1 Atkinson W, 
et al24
1996 RCT USA (single center, Alabama 
University Hospital)
May 1993 to 
December 
1994
Total participants n = 643 
*Spontaneous removal of 
placenta (SROP) n = 320 
*Manual removal of 
placenta (MROP) n = 323
ELCS/ EMCS Women requiring 
cesarean hysterectomy 




with 1% povidone- 
iodine solution and 
iodophor- isopropyl 
alcohol, surgeons 





Glove change before 
SROP 
or MROP 




Primary end point: 
endometritis defined 
as 38°C ± uterine 
tenderness or foul- 
smelling lochia in the 
absence of other source 
of sepsis
No data
2 Turrentine M, 
et al22






Total (all with MROP) n = 228 Women in labor  
undergoing CS




preparation and aseptic 
surgical technique 
Prophylactic antibiotics 
after clamping the 
umbilical cord Placenta 
uterus exteriorized in 
all CS
Glove change before 
MROP n = 113
No glove change 
and MROP 
 = 115
Primary end point: 
endometritis defined as 
oral temperature ≥38°C 
twice at least 6 h apart 
and 24 h after delivery, 
uterine tenderness and 
peripheral leukocytosis 
(≥15 000 cells/mL) in the 







3 Cernadas M, 
et al23





Total n = 108 *Expressed 
removal of placenta 
(EROP) n = 55 *MROP 
n = 53
ELCS/ EMCS Multiple pregnancies 
Pre- existing 
maternal infective 




Surgical preparation with 
iodophor detergent 
(0.75% iodine) solution, 
and painted with 1% 
povidone- iodine topical 
solution
Glove change before 
EROP  = 28
or MROP  = 27
No glove change 
before
EROP  = 27
or MROP 
Primary end point: (1) 
postpartum febrile 
morbidity defined as 
temperature ≥38°C after 
the first 24 h post- CS (2) 
endometritis diagnosed 
with temperature 
≥38°C 24 h after CS 
and significant uterine 
tenderness in the absence 
of another source of 
sepsis (3) Length of 










2004 RCT Hungary (data about number 
of centers not provided)
Data not 
available
Total participants n = 241 CS Similar between two groups Change gloves after 
SROP  = 151




Primary end point: 
endometritis
Data not 
5 Ventolini G, 








Total participants n = 92 CS SROM, morbidly obese 
women, ≥3 VE, 
prepregnancy diabetes
Data not available Glove change after 
delivery of 
placenta 
No glove change Primary end point: (1) 
wound infection, (2) 
from wound infection
Data not 
6 Devoor A, 
et al8
2014 RCT India (data about number of 
centers not provided but 
assumed to be single- 
centered as ethics for the 




Total participants n = 150 CS with intact  
membranes or  
rupture of  
membranes  
<4 h, <3 cm
Morbid obesity (BMI 
>30 kg/m ), rupture of 






Glove change after 
delivery of the 
baby (by whole 
operating team) 
 = 50 Glove 
change after 




No glove change 
 = 50
Primary end point: (1) febrile 
morbidity defined as 
≥38.2°C twice at least 
6 h apart and 24 h after 
CS (2) wound infection 
defined as the presence 
of cellulitis, purulent 
discharge from incision 
site or fluctuant tender 
and erythematous 
incision margins (3) foul- 
smelling lochia
(Continues)
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prophylaxis Intervention Comparison Outcomes Follow- up
Atkinson W, 
et al
RCT USA (single center, Alabama 
University Hospital)
May 1993 to Total participants 
*Spontaneous removal of 
placenta (SROP) 
*Manual removal of 
placenta (MROP) 
ELCS/ EMCS Women requiring 
cesarean hysterectomy 




with 1% povidone- 
iodine solution and 
iodophor- isopropyl 
alcohol, surgeons 





Glove change before 
SROP n = 164
or MROP n = 161
No glove change 
and SROP 
n = 156
or MROP n = 162
Primary end point: 
endometritis defined 
as 38°C ± uterine 
tenderness or foul- 
smelling lochia in the 











Total (all with MROP)  = 228 Women in labor 
undergoing CS




preparation and aseptic 
surgical technique 
Prophylactic antibiotics 
after clamping the 
umbilical cord Placenta 
manually removed and 
uterus exteriorized in 
all CS
Glove change before 
MROP n = 113
No glove change 
and MROP 
n = 115
Primary end point: 
endometritis defined as 
oral temperature ≥38°C 
twice at least 6 h apart 
and 24 h after delivery, 
uterine tenderness and 
peripheral leukocytosis 
(≥15 000 cells/mL) in the 













Total  = 108 *Expressed 
removal of placenta 
(EROP)  = 55 *MROP 
 = 53
ELCS/ EMCS Multiple pregnancies 
Pre- existing 
maternal infective 




Surgical preparation with 
iodophor detergent 
(0.75% iodine) solution, 
and painted with 1% 
povidone- iodine topical 
solution
Glove change before 
EROP n = 28
or MROP n = 27
No glove change 
before
EROP n = 27
or MROP n = 26
Primary end point: (1) 
postpartum febrile 
morbidity defined as 
temperature ≥38°C after 
the first 24 h post- CS (2) 
endometritis diagnosed 
with temperature 
≥38°C 24 h after CS 
and significant uterine 
tenderness in the absence 
of another source of 
sepsis (3) Length of 









RCT Hungary (data about number 
of centers not provided)
Data not Total participants CS Similar between two groups Change gloves after 
SROP n = 151









5 Ventolini G, 
et al 35 (only 
published 
abstract)
RCT USA (single center, Wright 
State University)
Data not Total participants CS SROM, morbidly obese 
women, ≥3 VE, 
prepregnancy diabetes
Data not available Glove change after 
delivery of 
placenta n = 46
No glove change 
n = 46
Primary end point: (1) 







RCT India (data about number of 
centers not provided but 
assumed to be single- 
centered as ethics for the 
study was obtained in 
one institution)
Data not Total participants  = 150 CS with intact 
rupture of 
<4 h, <3 cm
Morbid obesity (BMI 
>30 kg/m2), rupture of 






Glove change after 
delivery of the 
baby (by whole 
operating team) 
n = 50 Glove 
change after 




No glove change 
n = 50
Primary end point: (1) febrile 
morbidity defined as 
≥38.2°C twice at least 
6 h apart and 24 h after 
CS (2) wound infection 
defined as the presence 
of cellulitis, purulent 
discharge from incision 
site or fluctuant tender 
and erythematous 
incision margins (3) foul- 
smelling lochia
(Continues)
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The asymmetry of the data was quantitatively assessed with the 
Egger's regression test (normalized effect estimate against preci-
sion)30 with low p values deemed indicative of potential publica-
tion bias.
2.10  |  GRADE/ Summary of Findings tables
We employed the Quality assessment Grading of Recommendations, 
Assessment, Development and Evaluation (GRADE) approach to 
determine the certainty of the evidence related to the primary and 
secondary outcomes and inform future clinical recommendations.31 
We used the five GRADE considerations (study limitations, consist-
ency of effect, imprecision, indirectness, and publication bias). We 
justified all decisions to downgrade the certainty of studies using 
footnotes. A “Summary of findings” table was prepared accordingly 
using the GRADEpro software (GRADEpro GDT 2015).
3  |  RESULTS
3.1  |  General characteristics of the studies 
included
The database search yielded a total of 104 studies, 35 of which were 
excluded for duplication (Appendix S1). One further study was re-
trieved from searching references and gray literature to give a total 
of 70 articles. The titles and abstracts of these papers were assessed 
against the eligibility criteria, and 61 further studies were excluded 
for not addressing the outcome of interest (n = 45), not being RCTs 
(n = 13) or being published partially as commentaries (n = 3). The re-
maining nine papers were read in depth, three of which were only 
available as abstracts.32– 34 Several attempts were made to contact 
the authors of these studies without success. One of the abstracts 
was excluded because there were insufficient data for analysis.33 For 
outcomes in which abstracts were included, sensitivity analysis with 
and without these studies was planned in view of the limited infor-
mation available. However, such analysis was not always possible. 
A further study was also excluded for not being an RCT.16 Overall, 
seven primary research papers were included in the systematic re-
view with outcome data from a total of 1948 women. The literature 
search strategy is illustrated in Figure 1.
The timing of the intervention varied across studies. In three RCTs, 
the gloves were changed immediately before delivery of the placenta 
(n = 979),18– 20 in another three studies they were changed after delivery 
of the placenta (n = 819).21,32,34 Only one study compared glove change 
before and after delivery of the placenta (n = 150)17 as a three- arm trial. 
For this study in particular, data were first analyzed based on interven-
tion, i.e. glove change (n = 100) versus control (n = 50) regardless of the 
timing of glove changing before proceeding to subgroup analysis.
Some studies also randomized patients based on the method to 
remove the placenta including manual, expressed, and/or sponta-
neous removal of the placenta (Table 1).
3.2  |  Methodological quality assessment
Methodological information was not available for the two abstracted 
studies included in the review, which were automatically deemed at 





design Country Study period Sample size Inclusion criteria Outcomes
7 Scrafford J, 
et al25
2018 RCT USA (single center, 
HealthPartners Regions 






Total number of participants 
n = 486







surgical technique at 
the discretion of the 
attending surgeon
Change of gloves 
prior to 
closure - closure 
of the perineum 
and/or fascia 
No glove change 
 = 250
Primary end point: 
(1) wound- related 
complications understood 
as hematoma, seroma, 
gaping >1 cm, wound 
infection or any 
abnormality of the 
wound) Secondary 
end points: (2) febrile 
morbidity defined as 
≥38° prior to hospital 
discharge, (3) cellulitis, 
(4) endometritis, (5) 
infectious complications 
defined as the occurrence 





Abbreviations: BMI, body mass index; ELCS, elective cesarean section; EMCS, emergency cesarean section; EROP, expressed delivery of placenta;  
MROP, manual removal of placenta; RCT, randomized controlled trial; SROM, spontaneous rupture of membranes; SROP, spontaneous removal of  
placenta; VE, vaginal examination.
TA B L E  1  (Continued)
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Four studies described the randomization process,18– 21 out of 
which three specified the concealment allocation.19– 21 The method 
of randomization and allocation was unclear in the remaining stud-
ies. Only one study blinded outcomes to the investigators,19 and one 
to the patients but not the surgeons.21
All studies offered similar concurrent treatment to intervention 
and control groups except for the trial by Cernadas et al in which the 
preoperative preparation of the patient, perioperative administra-
tion of antibiotics, and surgical technique were left to the discretion 
of the surgeon.19
Four studies18– 21 provided sample size calculation with tar-
get samples being achieved in three of these studies except for 
Cernadas et al.19 With the exception of the two abstracted stud-
ies,32,34 all remaining studies defined clear and measurable out-
comes though not necessarily standardized definitions. Follow up 
and intention- to- treat, on the other hand, was only reported in three 
of the studies.18,19,21
Each study tried to adjust for potential confounding factors in-
cluding patient's age, body mass index, parity, gestational age at time 
of delivery, indication of CS, presence of labor, rupture of membranes, 
concomitant preoperative preparation— antibiotics/scrubbing, num-
ber of vaginal examinations, and insertion of intrauterine fetal devices. 
However, not all studies addressed the same variables and when they 
did they were not always equally distributed across studies.
Overall, two studies20,21 were classified as high methodological 
quality, two as of moderate quality,18,19 and the remaining three as 
of low quality17,32,34 (Figure 2; Table S2).
When the studies included in the review were assessed with 
GRADEpro,31 the recommendations derived from our review were 
graded of moderate quality (Table S3).
3.3  |  Publication bias
The funnel plots for the primary and secondary outcomes were 
rather symmetrical, suggesting low evidence of publication bias 
(Figure 3). This visual assessment was further supported by the 
Egger's regression test, which was not significant for any of the out-
comes assessed (wound infective complication, p = 0.73; endometri-
tis, p = 0.72; febrile morbidity, p = 0.45).
3.4  |  Synthesis of the results
3.4.1  |  Primary outcome: Wound infective 
complications
Four studies17,19,21,34 compared the incidence of wound infective 
complications when changing gloves. Information from a total 
of 836 women was included for this outcome, of whom 52.27% 
(n = 437) were in the glove changing groups and 47.73% (n = 399) 
in the control groups. Wound infective complications were signifi-
cantly lower in the glove changing groups (RR 0.41, 95% CI 0.26– 
0.65, p < 0.0001). Further subgroup analysis showed that changing 
the gloves after delivery of placenta (RR 0.39, 95% CI 0.24– 0.63, 
p < 0.0002)17,21,34 but not before (RR 0.62, 95% CI 0.15– 2.49, 
p = 0.5)17,19 was associated with a lower incidence of wound infec-
tive complications.
Heterogeneity across all studies was noted to be low as sug-
gested by a heterogeneity index I2 = 0% (Figure 4A). Even when 
the subgroup analysis suggested greater heterogeneity among tri-




prophylaxis Intervention Comparison Outcomes Follow- up
7 Scrafford J, 
et al25
2018 RCT USA (single center, 
HealthPartners Regions 




Total number of participants 
 = 486







surgical technique at 
the discretion of the 
attending surgeon
Change of gloves 
prior to 
abdominal 
closure - closure 
of the perineum 
and/or fascia 
n = 236
No glove change 
n = 250
Primary end point: 
(1) wound- related 
complications understood 
as hematoma, seroma, 
gaping >1 cm, wound 
infection or any 
abnormality of the 
wound) Secondary 
end points: (2) febrile 
morbidity defined as 
≥38° prior to hospital 
discharge, (3) cellulitis, 
(4) endometritis, (5) 
infectious complications 
defined as the occurrence 





Abbreviations: BMI, body mass index; ELCS, elective cesarean section; EMCS, emergency cesarean section; EROP, expressed delivery of placenta; 
MROP, manual removal of placenta; RCT, randomized controlled trial; SROM, spontaneous rupture of membranes; SROP, spontaneous removal of 
placenta; VE, vaginal examination.
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delivery of the placenta, heterogeneity was still low (I2 = 17%) 
(Figure 4B).
3.4.2  |  Secondary outcome (1): Endometritis
Five studies, which collectively assessed a total of 1706 women, reported 
on the incidence of endometritis after changing gloves during a CS com-
pared with routine care.18– 21,32 Just over half of the participants were 
allocated to the intervention group (51.58%, n = 880), whereas 48.42% 
of the women were in the control group (n = 826). Changing gloves intra-
operatively was not associated with a significant change in the incidence 
of endometritis (RR 0.96, 95% CI 0.78– 1.20, p = 0.74) (Figure 5A).
Three of these studies assessed glove changing before removing 
the placenta,18– 20 whereas the remaining two evaluated the impact of 
the intervention after delivery of the placenta.21,32 Further subgroup 
analysis based on the timing of the intervention, however, did not 
seem to statistically affect the incidence of endometritis (Figure 5B).










































Not outcome of 
interest (n = 45)
Not RCT (n = 13)
Commentary/ 
Incomplete data (n = 3)
Full-text or abstracted 
articles assessed for 
eligibility
(n = 9)





Not RCT (n = 1)
Studies included in 
meta-synthesis 
(n = 7)
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F I G U R E  2  (A) Risk of bias graph for the studies included in this systematic review, (B) overall bias risk assessment suggests relatively high 
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Similarly to the primary outcome, the heterogeneity across stud-
ies for endometritis was low (I2 = 0%).
3.4.3  |  Secondary outcome (2): Febrile morbidity
Three studies compared the incidence of febrile morbidity in 744 
women based on whether gloves were changed during the CS or 
not.17,19,21 The distribution of participants between the intervention 
and control groups was similar (intervention: 52.55%, n = 391; control: 
47.45%, n = 353).
No statistically significant differences were identified on post-
operative febrile morbidity regardless of whether the gloves were 
changed before and/or after delivery of the placenta (RR 0.73, 95% 
CI 0.30– 1.81, p = 0.50) (Figure 6A and B).
Contrary to the other outcomes, heterogeneity across studies 
for febrile morbidity was deemed moderate (I2 = 58%), which re-
solved when studies were grouped by timing of the intervention 
(Figure 6B).
4  |  DISCUSSION
Infective complications after CS continue to be a frequent cause of 
postoperative morbidity, which not only adversely affects the physi-
cal and emotional well- being of the new mothers and their families but 
also places a heavy financial burden on strained healthcare systems.35 
Specifically for the National Health Service, reducing CS- related SSI could 
lower the cost of managing postoperative infections by up to £4000 per 
case with shorter hospitalization times and decreased need for antibiot-
ics.36,37 Therefore, cost- effective interventions that are easy to perform 
are urgently needed as an attempt to counteract these complications. 
Our systematic review suggests that minimal but key changes to current 
clinical practice may play an instrumental role in this global effort.
WHO has previously assessed the effectiveness of double- 
gloving, the criteria for changing gloves during an operation, and 
the types of gloves to be used to prevent SSI.38 However, to the 
best of our knowledge, our review is the first to systematically 
evaluate the effects of changing gloves at different stages of CS 
on postoperative infective complications. We have shown that 
F I G U R E  3  Funnel plots for the meta- analysis of included studies for the main outcome (A) wound infective complication, and the 
secondary outcomes (B) endometritis and (C) febrile morbidity. The triangle lines represent the regions in which 95% of the data points 
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changing gloves intraoperatively significantly decreases the inci-
dence of wound infective complications, but it does not affect the 
incidence of endometritis or febrile morbidity. We have also high-
lighted that timing of the intervention plays a major role. Whereas 
no benefits have been found for changing gloves before delivery of 
the placenta, it may prove effective for reduction of wound infec-
tion if performed after delivery of the placenta and before closing 
the abdominal wall. This finding is consistent with previous stud-
ies that evaluated infection prevention bundles for CS and found 
that changing gloves intraoperatively after delivery of the placenta 
when assessed in conjunction with other interventions such as ch-
lorhexidine preparation, perioperative antibiotics, and removal of 
placenta by gentle traction might reduce the incidence of SSI.8,39 
Other specialties like Urology and Colorectal, however, have not 
found any statistically significant differences in postoperative in-
fective complications after changing gloves, which we think may be 
due to intrinsic differences in the surgical nature of CS compared 
with other operations.4,21
Even though the pathophysiology of SSI following CS remains 
to be fully elucidated, we hypothesized that changing gloves intra-
operatively may be more effective to contain infection at a local 
rather than at a systemic level because it reduces contamination of 
the wound with commensal flora from the vagina during surgery. 
Postoperative low- grade febrile episodes, on the other hand, are 
not necessarily infective in nature and might represent a physiolog-
ical response to surgery.40 This would explain why changing gloves 
during CS may not be as effective at reducing postoperative fever 
as it is for wound complications. Endometritis may also be less af-
fected by intraoperative changing of gloves because its strongest 
risk factors tend to occur in the antenatal period and during labor 
(vaginal dysbiosis, prolonged rupture of membranes, multiple vaginal 
examinations).41 Therefore, interventions that are carried out during 
delivery such as intraoperative changing of gloves may have missed 
the window of opportunity.
The strength of our study relies on the relevance on the topic as 
well as on the robustness of the methodology employed to conduct 
the systematic review and subsequent meta- analysis. We thoroughly 
and systematically searched a wide range of electronic databases, 
references, and gray literature with clearly defined inclusion criteria 
against a peer- reviewed published protocol in PROSPERO.
However, we also recognize a series of limitations to our review. 
Certain end points of interest such as wound complications and en-
dometritis were defined differently across studies, which may have 
affected comparability (Table 1). Similarly, in some studies, the 
F I G U R E  4  (A) Forest plot showing the relationship of changing gloves during a CS and wound infective complications, (B) subgroup 
analysis by timing of changing gloves. Values show the risk ratio (95% CI) of wound complications using a random effect model [Color figure 
can be viewed at wileyonlinelibrary.com]
(A) 
(B)
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intervention was combined with different modes of placental de-
livery, which is likely to have affected the outcome.18– 20 McCurdy 
et al reported that expressed removal of the placenta could be re-
sponsible for a significant reduction in post- CS endometritis com-
pared with manual placental delivery (3% vs 23%, respectively; 
p < 0.05).42
In order to minimize the risk of publication bias, we attempted 
to consider all available data including small studies, which were 
published only in their abstracted form. Even though our analy-
ses suggested low risk of publication bias, we understand that the 
small number of studies available for each outcome of interest 
may have resulted in underpowered funnel plots to detect pub-
lication bias. Additionally, the inclusion of gray literature came at 
the expense of increasing other sources of systematic error be-
cause some key methodological information was missing in the ab-
stracted studies. Moreover, as the included studies spanned many 
decades, not all of them met the minimum reporting criteria set by 
the CONSORT (Consolidating Standards of Reporting Trials) state-
ment,43 which significantly affected the methodological quality 
assessment. Most studies did not blind participants, operators and 
assessors, which increased the risk of performance and detection 
biases. Furthermore, not all studies reported on whether potential 
confounding factors such as rupture of membranes and number of 
vaginal examinations had been addressed or provided information 
about intention- to- treat and loss to follow up.
Interestingly, none of the studies assessed whether changing 
gloves intraoperatively prolonged surgical time, and only Scrafford 
et al. acknowledged that changing gloves immediately after deliver-
ing the placenta could pose safety concerns.21
Therefore, although our systematic review strongly suggests 
that changing gloves after delivery of the placenta may prove use-
ful to reduce wound complications after CS, a formal health eco-
nomics evaluation and a comprehensive study of potential barriers 
to implementing this intervention in the clinical setting are still 
needed.
5  |  CONCLUSION
Changing gloves after delivery of the placenta during a CS may be 
associated with a significant reduction in the incidence of infective 
wound complications. Nonetheless, before this intervention can be 
F I G U R E  5  (A) Forest plot showing the relationship of changing gloves during a CS and endometritis, (B) subgroup analysis by timing 
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recommended as routine clinical practice, we believe a high- quality, 
adequately powered, multicenter RCT with a validated SSI defini-
tion as primary outcome should be conducted to evaluate the cost- 
effectiveness and acceptability of the intervention in the clinical 
setting.
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